Multiple studies support flexible approach to treating actinic keratoses with imiquimod


In early March, the FDA granted marketing approval for use of imiquimod cream in the treatment of nonhyperkeratotic, nonhypertrophic AKs on the scalp or face in immunocompetent individuals.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.